Partial response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic BRAF V600EMT colon cancer patient with acquired C-MET amplification and TPM4-ALK fusion: a case report

Yingying Huang, Shuai Zhang, Xueqing Hu, Xiangyang Wang, Yunbo Zhao, Zhongkang Li